These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8676424)

  • 21. The effect of allogeneic presensitization on H-Y graft survival and in vitro cell-mediated responses to H-y antigen.
    Gordon RD; Mathieson BJ; Samelson LE; Boyse EA; Simpson E
    J Exp Med; 1976 Sep; 144(3):810-20. PubMed ID: 784891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerated rejection of H-2-incompatible skin allografts in the absence of specific cytotoxic antibodies.
    Aitouche A; Touraine JL
    Transplantation; 1993 Sep; 56(3):503-8. PubMed ID: 8212140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acceptance of allogeneic fibroblasts in skin equivalent transplants.
    Sher SE; Hull BE; Rosen S; Church D; Friedman L; Bell E
    Transplantation; 1983 Nov; 36(5):552-7. PubMed ID: 6356519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of male-specific minor histocompatibility antigen H-Y in epidermal equivalent allograft rejection.
    Beaulieu MJ; Li H; Bergeron J; Ross G; Auger FA; Rouabhia M
    Cell Transplant; 1998; 7(1):11-23. PubMed ID: 9489759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term survival and immunological tolerance of human epidermal allografts produced in culture.
    Thivolet J; Faure M; Demidem A; Mauduit G
    Transplantation; 1986 Sep; 42(3):274-80. PubMed ID: 3750385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplantation of cryopreserved cultured epidermal allografts.
    Madden MR; LaBruna AA; Hajjar DP; Staiano-Coico L
    J Trauma; 1996 May; 40(5):743-50. PubMed ID: 8614073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rejection of MHC incompatible, Langerhans cell-free epidermal keratinocyte allografts in the rat.
    Yeoman H; Munro AJ; Stanley MA
    Reg Immunol; 1990; 3(2):75-81. PubMed ID: 2088475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal allografts.
    Fabre JW
    Immunol Lett; 1991 Jul; 29(1-2):161-5. PubMed ID: 1916918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The reconstitution of living skin.
    Bell E; Sher S; Hull B; Merrill C; Rosen S; Chamson A; Asselineau D; Dubertret L; Coulomb B; Lapiere C; Nusgens B; Neveux Y
    J Invest Dermatol; 1983 Jul; 81(1 Suppl):2s-10s. PubMed ID: 6306115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Composite skin graft: frozen dermal allografts support the engraftment and expansion of autologous epidermis.
    Heck EL; Bergstresser PR; Baxter CR
    J Trauma; 1985 Feb; 25(2):106-12. PubMed ID: 3882973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of allogeneic presensitization on Hya-isograft survival.
    Suman L; Silobrcić V
    Immunol Lett; 1994 Jun; 41(1):9-12. PubMed ID: 7959908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major histocompatibility complex class I presentation of exogenously acquired minor alloantigens initiates skin allograft rejection.
    Oukka M; Galou M; Belkaid Y; Tricotet V; Riche N; Reynes M; Kosmatopoulos K
    Eur J Immunol; 1997 Dec; 27(12):3499-506. PubMed ID: 9464840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of cultured epidermal autografts and dermal allografts as skin replacement after burn injury.
    Cuono C; Langdon R; McGuire J
    Lancet; 1986 May; 1(8490):1123-4. PubMed ID: 2422513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Culture of keratinocytes for transplantation without the need of feeder layer cells.
    Coolen NA; Verkerk M; Reijnen L; Vlig M; van den Bogaerdt AJ; Breetveld M; Gibbs S; Middelkoop E; Ulrich MM
    Cell Transplant; 2007; 16(6):649-61. PubMed ID: 17912956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Observation of expression of ABH blood group antigens in cultured epidermis and its allograft].
    Zhao YB
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1993 Jan; 9(1):34-6, 78. PubMed ID: 8330242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mixed cultures comprising syngeneic and allogeneic mouse keratinocytes as a graftable skin substitute.
    Suzuki T; Ui K; Shioya N; Ihara S
    Transplantation; 1995 May; 59(9):1236-41. PubMed ID: 7762054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of unresponsiveness to major transplantable organs in adult mammals: a recapitulation of ontogeny by irradiation and bone marrow replacement.
    Rapaport FT; Bachvaroff RJ; Mollen N; Hirasawa H; Asano T; Ferrebee JW
    Ann Surg; 1979 Oct; 190(4):461-73. PubMed ID: 384942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection.
    Jones ND; Turvey SE; Van Maurik A; Hara M; Kingsley CI; Smith CH; Mellor AL; Morris PJ; Wood KJ
    J Immunol; 2001 Feb; 166(4):2824-30. PubMed ID: 11160350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.